A Message From The ESCRS President


Rudy Nuijts
Published: Sunday, March 22, 2020

Dear Colleagues
It is my home country, The Netherlands, where we shine a spotlight today. In Maastricht (my home) we have cancelled all elective surgery and some colleagues are preparing to take place in other departments of medicine when/if the need arises. I have shared with you here a number of protocols we have developed to guide our activities over the coming days. These will be available on www.eurotimes.org in Dutch and English (tomorrow).
Our synopsis in this issue is taken from an article by Christian Hoebe, head of infection prevention at the Dutch National Public Health Institutes (GGD) of South Limburg and member of the Outbreak Management Team of the Dutch government, who sets out the Dutch position on dealing with the COVID 19 threat.
It is not for the ESCRS to enter into the great debate among political decisionmakers and medical experts on the optimum means of dealing with this crisis. Nor to pass comment on the many bloggers and influencers active on social media. It will be sometime after we are through this pandemic that the advantages and disadvantages of all the various strategies will become clear. This healthcare crisis calls for leadership and decision taking amid an environment where management of uncertainty probably is the most difficult part.
It is our plan and the purpose of this newsletter to communicate the views of the people who are involved in the management of this crisis in each particular country and to share the experiences of our colleagues who are in the front lines of this battle.
We have all known for a long time that EU member states are not harmonised in their healthcare policies. Hopefully this crisis will provoke a paradigm shift for the future and lead to the level of solidarity and cooperation that we now already see on a micro level in our hospitals.
Please stay safe and well.


Prof. dr Rudy MMA Nuijts
ESCRS President
READ THE FULL NEWSLETTER HERE
http://createsend.com/t/r-FE041C7B6084E1C12540EF23F30FEDED
Tags: covid-19
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.